ATE131072T1 - Kerne für technetium-radioarzneimittel. - Google Patents

Kerne für technetium-radioarzneimittel.

Info

Publication number
ATE131072T1
ATE131072T1 AT90914225T AT90914225T ATE131072T1 AT E131072 T1 ATE131072 T1 AT E131072T1 AT 90914225 T AT90914225 T AT 90914225T AT 90914225 T AT90914225 T AT 90914225T AT E131072 T1 ATE131072 T1 AT E131072T1
Authority
AT
Austria
Prior art keywords
technetium
substituted
complexes
radiomedicinal
cores
Prior art date
Application number
AT90914225T
Other languages
English (en)
Inventor
Colin Mill Archer
Amersham Place Plc
Jonathan Robin Dept O Dilworth
Of Essex Wivenhoe P University
Panna Jobanputra
Ian Andrew Latham
Russell Martin Dept O Thompson
Original Assignee
Amersham Int Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10662202&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE131072(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amersham Int Plc filed Critical Amersham Int Plc
Application granted granted Critical
Publication of ATE131072T1 publication Critical patent/ATE131072T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0476—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from monodendate ligands, e.g. sestamibi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT90914225T 1989-08-29 1990-08-28 Kerne für technetium-radioarzneimittel. ATE131072T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898919488A GB8919488D0 (en) 1989-08-29 1989-08-29 New cores for technetium radiopharmaceuticals

Publications (1)

Publication Number Publication Date
ATE131072T1 true ATE131072T1 (de) 1995-12-15

Family

ID=10662202

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90914225T ATE131072T1 (de) 1989-08-29 1990-08-28 Kerne für technetium-radioarzneimittel.

Country Status (7)

Country Link
EP (1) EP0441953B1 (de)
JP (2) JP3221875B2 (de)
AT (1) ATE131072T1 (de)
CA (1) CA2039732A1 (de)
DE (1) DE69024038T2 (de)
GB (1) GB8919488D0 (de)
WO (1) WO1991003262A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0662001A4 (de) * 1991-11-08 1995-11-22 Univ Missouri Multifunktionelle Liganden zur potentiellen Verwendung für das Design therapeutischer oder diagnostischer radiopharmazeutischer bildgebender Wirk-stoffe.
US5750088A (en) * 1993-03-30 1998-05-12 The Dupont Merck Pharmaceutical Company Stable hydrazones linked to a peptide moiety as reagents for the preparation of radiopharmaceuticals
US5744120A (en) * 1993-03-30 1998-04-28 The Dupont Merick Pharmaceutical Company Ternary radiopharmaceutical complexes
US5879657A (en) * 1993-03-30 1999-03-09 The Dupont Merck Pharmaceutical Company Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
US5541289A (en) * 1994-03-30 1996-07-30 Washington University Phosphine containing amino acids and peptides and methods of preparing and using same
IT1286879B1 (it) * 1996-11-21 1998-07-17 Consiglio Nazionale Ricerche Leganti 1,3-difosfinopropanici e complessi da essi formati con metalli di transizione,loro preparazione e uso
US6403054B1 (en) 1997-05-28 2002-06-11 Bristol-Myers Squibb Pharma Company Ternary ligand complexes useful as radiopharmaceuticals
US6251364B1 (en) 1999-03-29 2001-06-26 Dupont Pharmaceuticals Company Ternary ligand complexes useful as radiopharmaceuticals
US6534038B2 (en) 2000-04-07 2003-03-18 Bristol-Myers Squibb Pharma Company Ternary ligand complexes useful as radiopharmaceuticals
US6517814B2 (en) 2001-01-09 2003-02-11 Bristol-Myers Squibb Pharma Company Macrocyclic chelants useful for metallopharmaceuticals
US6776977B2 (en) 2001-01-09 2004-08-17 Bristol-Myers Squibb Pharma Company Polypodal chelants for metallopharmaceuticals
US6794553B2 (en) * 2001-11-09 2004-09-21 Shell Oil Company Process for the telomerization of a conjugated diene, catalyst and bidentate ligand useful therein
EP1417977A1 (de) * 2002-11-07 2004-05-12 BRACCO IMAGING S.p.A. Radioaktive Übergangsmetall-Imido-Heterodiphosphinkomplexe; deren Herstellung und radiopharmazeutische Zusammensetzungen

Also Published As

Publication number Publication date
JP2002060397A (ja) 2002-02-26
DE69024038T2 (de) 1996-04-25
JP3341001B2 (ja) 2002-11-05
DE69024038D1 (de) 1996-01-18
CA2039732A1 (en) 1991-03-01
GB8919488D0 (en) 1989-10-11
JP3221875B2 (ja) 2001-10-22
WO1991003262A1 (en) 1991-03-21
JPH04506810A (ja) 1992-11-26
EP0441953A1 (de) 1991-08-21
EP0441953B1 (de) 1995-12-06

Similar Documents

Publication Publication Date Title
ATE131072T1 (de) Kerne für technetium-radioarzneimittel.
DK202788A (da) Nitrogenholdge cykliske ligander, metalkomplekser dannet af disse ligander, diagnostiske praeparater der indeholder disse komplekser samt fremgangsmaade til fremstilling af liganderne
NO301829B1 (no) 2-pyridylmetylenpolyazamakrocyklo-fosfonsyrer, komplekser og farmasöytiske preparater basert på disse
ES457415A1 (es) Un procedimiento para la preparacion de un virador ferromag-netico.
DE69010700D1 (de) Messung magnetischer Felder.
DE69004753T2 (de) Farbstoffboratkomplexe.
NL186961B (nl) Cyclische organofosforverbindingen en kunststoffen die deze verbindingen als vlamvertragers bevatten.
DK169086D0 (da) Boronsyreaddukter af technetium-99m-dioxim-komplekser
DE3774286D1 (de) (2,2-bis(aminomethyl)-1,3-propandiol-n,n')platin-komplexe.
IT1141151B (it) Nuclei peptidici ciclici
DK266689A (da) Kationiske komplekser med technetium-99m
SE422073B (sv) Forfarande for industriell framstellning av azofergemnen, som innehaller cyanogrupper, i en organisk sulfid som lesningsmedel och med en organisk kopparkomplexforening som katalyator
DK464586A (da) Phosphorforbindelser
IT8920145A0 (it) Apparecchiatura per applicazioni magnetiche mediante campi magnetici pulsanti, in particolare per magnetoterapia.
ES429967A1 (es) Procedimiento de obtencion de un preparado antigeno.
DE68909981T2 (de) Magnetische Hysteresiskupplung für Pumpen der Roots-Bauart.
AT359206B (de) Technetium-99m-markiertes nierendiagnostikum und verfahren zu seiner herstellung
DE3767847D1 (de) Geraet zur messung von magnetischen feldern.
FR2249859A1 (en) Isoindoline nitroxide radicals - useful as spin markers of biological molecules and in magnetometry
DE3884300D1 (de) Magnetische Polymerzusammensetzungen.
ES2021944A6 (es) Procedimiento para preparar nuevos derivados de 1,3,5,-triamino-2,4,6-triyodobenceno.
KORCHMAROS Representation of the identity matrix via a commutative field as cyclic matrix sum- An application in the theory of the'n-corner'
Wagenveld et al. Employment Generation Through Stimulation of Small Industries. List of Subject Headings Used by the International Development Data Center
IT8022087A0 (it) Estreno (2, 3-d) diidroisossazoldio lie processo di preparazione deglistessi.
IT1212880B (it) Complessi metalliferi 1:2, loro preparazione e loro impiego come coloranti